Applied Therapeutics, Inc.
APLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $10 | $8 | $12 |
| Gross Profit | $1 | -$10 | -$8 | -$12 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $10 | $10 | $8 | $12 |
| G&A Expenses | $9 | $13 | $17 | $21 |
| SG&A Expenses | $9 | $13 | $18 | $21 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | -$10 | -$8 | -$12 |
| Operating Expenses | $18 | $13 | $18 | $21 |
| Operating Income | -$17 | -$23 | -$26 | -$33 |
| % Margin | -1,675.8% | – | – | – |
| Other Income/Exp. Net | -$2 | $2 | $4 | $77 |
| Pre-Tax Income | -$19 | -$21 | -$22 | $44 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$19 | -$21 | -$22 | $44 |
| % Margin | -1,899% | – | – | – |
| EPS | -0.13 | -0.15 | -0.15 | 0.32 |
| % Growth | 13.3% | 0% | -146.9% | – |
| EPS Diluted | -0.13 | -0.15 | -0.15 | 0.32 |
| Weighted Avg Shares Out | 146 | 145 | 145 | 140 |
| Weighted Avg Shares Out Dil | 146 | 145 | 145 | 140 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$19 | -$23 | -$26 | -$33 |
| % Margin | -1,887.9% | – | – | – |